Cost Effectiveness Analysis of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer In Spain: Management in the Later Lines of Therapy
2014 ◽
Vol 147
(2)
◽
pp. 443-443
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. e11531-e11531
2016 ◽
Vol 160
(1)
◽
pp. 187-196
◽
2019 ◽
Vol 22
(6)
◽
pp. 584-592
◽